Published in JAMA on January 17, 1996
Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial. Lancet Infect Dis (2013) 3.61
Antimicrobial stewardship programs in health care systems. Clin Microbiol Rev (2005) 3.27
Consumer attitudes and use of antibiotics. Emerg Infect Dis (2003) 2.20
Development of a clinical data warehouse for hospital infection control. J Am Med Inform Assoc (2003) 2.02
Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock--a systematic review and meta-analysis. Crit Care (2013) 1.88
Antimicrobial resistance in Canada. CMAJ (2002) 1.81
Nosocomial infection update. Emerg Infect Dis (1998) 1.78
The contributions of biomedical informatics to the fight against bioterrorism. J Am Med Inform Assoc (2002) 1.75
Controlling antimicrobial resistance in hospitals: infection control and use of antibiotics. Emerg Infect Dis (2001) 1.74
Antibiotic use in Ontario facilities that provide chronic care. J Gen Intern Med (2001) 1.70
Impact of an antimicrobial utilization program on antimicrobial use at a large teaching hospital: a randomized controlled trial. Infect Control Hosp Epidemiol (2009) 1.60
Antibiotic resistance of urinary tract pathogens and rationale for empirical intravenous therapy. Pediatr Nephrol (2004) 1.28
Chlorhexidine body washing to control antimicrobial-resistant bacteria in intensive care units: a systematic review. Intensive Care Med (2012) 1.27
Methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci in rural communities, western United States. Emerg Infect Dis (2005) 1.20
Antibiotic stewardship in the intensive care unit. Crit Care (2014) 1.18
Discrepancies between prescribed daily doses and WHO defined daily doses of antibacterials at a university hospital. Br J Clin Pharmacol (2006) 1.18
Activities of a nitrofurazone-containing urinary catheter and a silver hydrogel catheter against multidrug-resistant bacteria characteristic of catheter-associated urinary tract infection. Antimicrob Agents Chemother (1999) 1.16
Antimicrobial resistance in hospitals: how concerned should we be? CMAJ (2009) 1.16
Antimicrobial resistance among nosocomial isolates in a teaching hospital in goa. Indian J Community Med (2008) 1.15
Response to emerging infection leading to outbreak of linezolid-resistant enterococci. Emerg Infect Dis (2007) 1.13
Rapid detection of antimicrobial-resistant organism carriage: an unmet clinical need. J Clin Microbiol (2004) 1.12
Systematic review of antimicrobial drug prescribing in hospitals. Emerg Infect Dis (2006) 1.11
Monitoring antimicrobial use and resistance: comparison with a national benchmark on reducing vancomycin use and vancomycin-resistant enterococci. Emerg Infect Dis (2002) 1.10
The epidemiology of antimicrobial resistance in hospital acquired infections: problems and possible solutions. BMJ (1998) 1.08
Antibiotic prescription and cost patterns in a general intensive care unit. Pharm Pract (Granada) (2007) 1.02
Optimizing antibiotic therapy in the intensive care unit setting. Crit Care (2001) 1.02
Mussel-inspired silver-releasing antibacterial hydrogels. Biomaterials (2012) 1.01
Structured representation of the pharmacodynamics section of the summary of product characteristics for antibiotics: application for automated extraction and visualization of their antimicrobial activity spectra. J Am Med Inform Assoc (2004) 0.98
Prescribing patterns of antibiotics and sensitivity patterns of common microorganisms in the Internal Medicine ward of a teaching hospital in Western Nepal: a prospective study. Ann Clin Microbiol Antimicrob (2003) 0.98
Variability in the content of Indian generic ciprofloxacin eye drops. Br J Ophthalmol (2005) 0.97
Systems approach to improving antimicrobial susceptibility testing in clinical laboratories in the United States. J Clin Microbiol (2007) 0.94
Bench-to-bedside review: antimicrobial utilization strategies aimed at preventing the emergence of bacterial resistance in the intensive care unit. Crit Care (2005) 0.93
Access to antibiotics: a safety and equity challenge for the next decade. Antimicrob Resist Infect Control (2013) 0.90
Procalcitonin biomarker kinetics fails to predict treatment response in perioperative abdominal infection with septic shock. Crit Care (2013) 0.86
Unnatural selection: reducing antibiotic resistance in neonatal units. Arch Dis Child Fetal Neonatal Ed (2006) 0.86
The American Society of Anesthesiologists physical status score and risk of perioperative infection. JAMA (1996) 0.86
The efficacy of clinical strategies to reduce nosocomial sepsis in extremely low birth weight infants. J Korean Med Sci (2005) 0.85
Rotation of antimicrobial therapy in the intensive care unit: impact on incidence of ventilator-associated pneumonia caused by antibiotic-resistant Gram-negative bacteria. Eur J Clin Microbiol Infect Dis (2010) 0.85
Decreasing antibiotic overuse in neonatal intensive care units: quality improvement research. Proc (Bayl Univ Med Cent) (2005) 0.85
Prospective assessment of fluoroquinolone use in a teaching hospital. Eur J Clin Microbiol Infect Dis (2006) 0.85
Pediatric vancomycin use in 421 hospitals in the United States, 2008. PLoS One (2012) 0.84
Antibiotic resistance - why is the problem so difficult to solve? Infect Ecol Epidemiol (2012) 0.83
Practice of switch from intravenous to oral antibiotics. Springerplus (2014) 0.83
Determination of antibiotics consumption in buali-sina pediatric hospital, sari 2010-2011. Iran J Pharm Res (2014) 0.82
Rapid detection of ampicillin resistance in Escherichia coli by quantitative mass spectrometry. J Clin Microbiol (2012) 0.82
Ventilator-Associated Pneumonia: When to hold the breath? Int J Crit Illn Inj Sci (2013) 0.82
Relationship between glycopeptide use and decreased susceptibility to teicoplanin in isolates of coagulase-negative staphylococci. Eur J Clin Microbiol Infect Dis (2004) 0.80
Antibiotic resistance in Canada at the dawn of the new millennium - a model for the developed world? Can J Infect Dis (2000) 0.80
Opinion: the clinical use of selective digestive decontamination. Crit Care (2000) 0.79
Principles and strategies of antimicrobial stewardship in the neonatal intensive care unit. Semin Perinatol (2012) 0.79
A prospective study on the antimicrobial usage in the medicine department of a tertiary care teaching hospital. J Clin Diagn Res (2013) 0.79
Decision analysis modelling of costs and outcomes following cefepime monotherapy in Canada. Can J Infect Dis (1997) 0.78
Determining the use of prophylactic antibiotics in breast cancer surgeries: a survey of practice. BMC Surg (2012) 0.78
Coisolation of Streptococcus pneumoniae and Hameophilus influenzae from middle ear fluid and sputum: effect on MIC results. J Clin Microbiol (1999) 0.78
Healthcare - associated infections: A public health problem. Niger Med J (2012) 0.77
Resistance Pattern of Antibiotics in Patient Underwent Open Heart Surgery With Nosocomial Infection in North of Iran. Glob J Health Sci (2015) 0.77
Factors associated with doctors' knowledge on antibiotic use in China. Sci Rep (2016) 0.77
Antimicrobial resistance - Judicious use is the key. Can J Infect Dis Med Microbiol (2004) 0.77
The post-antibiotic era beckons. J R Soc Med (1996) 0.77
Canadian Committee on Antibiotic Resistance report. Can J Infect Dis Med Microbiol (2004) 0.76
Determinants of the Final Size and Case Rate of Nosocomial Outbreaks. PLoS One (2015) 0.76
Pro/con clinical debate: the use of a protected specimen brush in the diagnosis of ventilator associated pneumonia. Crit Care (2002) 0.76
Comparison of Hospitalwide and Custom Antibiograms for Clinical Isolates of Pseudomonas aeruginosa. Hosp Pharm (2013) 0.76
Macrolide-resistant Streptococcus pneumoniae: clinical implications for the empiric treatment of community-acquired respiratory tract infections. MedGenMed (2005) 0.75
Surveillance of Antibiotic-Resistant Bacteria in King Khalid Hospital, Hafr Al-Batin, Saudi Arabia, During 2013. Jundishapur J Microbiol (2016) 0.75
Peri-Operative Bacteraemia in Burn Patients. What Does it Mean? Ann Burns Fire Disasters (2006) 0.75
Antimicrobial use and antimicrobial resistance in nosocomial pathogens at a tertiary care hospital in Pune. Med J Armed Forces India (2015) 0.75
[Bacterial ecology of nosocomial infection in intensive care unit of Laquintinie hospital Douala, Cameroon]. Pan Afr Med J (2013) 0.75
Strategies for controlling antibiotic use in a tertiary-care paediatric hospital. Paediatr Child Health (1997) 0.75
Staphylococcus aureus infections in children in an Iranian referral pediatric hospital. J Prev Med Hyg (2013) 0.75
Implementation of a procalcitonin-guided algorithm for antibiotic therapy in the burn intensive care unit. Ann Burns Fire Disasters (2015) 0.75
Is there really a survival benefit of SDD in burns? Ann Surg (2006) 0.75
Nosocomial infections and antibiotic resistance pattern in open-heart surgery patients at Imam Ali Hospital in Kermanshah, Iran. GMS Hyg Infect Control (2017) 0.75
Prophylactic antibiotics for percutaneous endovascular procedures. Eur J Clin Microbiol Infect Dis (2016) 0.75
Antimicrobial use and microbiological testing in district general hospital ICUs of the Veneto region of north-east Italy. Eur J Clin Microbiol Infect Dis (2016) 0.75
Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis (1999) 10.30
The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA (1995) 9.54
Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. Am J Med (1991) 9.11
Major trends in the microbial etiology of nosocomial infection. Am J Med (1991) 8.56
CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol (1992) 8.28
An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev (1993) 8.03
Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med (1999) 7.90
Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch Intern Med (1988) 6.78
The emergence of methicillin-resistant Staphylococcus aureus infections in United States hospitals. Possible role of the house staff-patient transfer circuit. Ann Intern Med (1982) 6.62
Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum. J Infect Dis (1974) 6.38
Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA (1994) 6.11
Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991. Infect Control Hosp Epidemiol (1992) 5.98
A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis. N Engl J Med (1979) 5.87
Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med (1982) 5.46
Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol (2000) 5.38
Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units. N Engl J Med (1992) 5.28
Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA (1999) 5.26
Surgical wound infection rates by wound class, operative procedure, and patient risk index. National Nosocomial Infections Surveillance System. Am J Med (1991) 4.72
Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis (1995) 4.36
Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis (2002) 4.35
Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr (1985) 4.26
Coagulase-negative staphylococcal bacteremia. Mortality and hospital stay. Ann Intern Med (1989) 4.23
Enhanced isolation of Mycoplasma pneumoniae from throat washings with a newly-modified culture medium. J Infect Dis (1979) 4.15
Multidrug-resistant tuberculosis. Ann Intern Med (1992) 4.06
Predominant pathogens in hospital infections. J Antimicrob Chemother (1992) 3.79
Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis (1999) 3.77
Systemic inflammatory response syndrome, sepsis, severe sepsis and septic shock: incidence, morbidities and outcomes in surgical ICU patients. Intensive Care Med (1995) 3.75
Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis (2001) 3.75
National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathogens of Epidemiologic. Diagn Microbiol Infect Dis (1998) 3.58
Vancomycin-resistant Staphylococcus aureus: perspectives on measures needed for control. Ann Intern Med (1996) 3.53
A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group. JAMA (1991) 3.25
Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment. Ann Intern Med (1991) 3.24
Methicillin-resistant Staphylococcus aureus: introduction and spread within a hospital. Ann Intern Med (1980) 3.20
Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey study group. Pediatr Infect Dis J (2000) 3.13
Association of slime with pathogenicity of coagulase-negative staphylococci causing nosocomial septicemia. J Clin Microbiol (1985) 3.13
5-Fluorocytosine in human cryptococcosis. Antimicrob Agents Chemother (Bethesda) (1968) 3.08
Nosocomial infection rates in adult and pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Am J Med (1991) 3.06
Colonization of skilled-care facility residents with antimicrobial-resistant pathogens. J Am Geriatr Soc (2001) 3.06
National nosocomial infections surveillance system (NNIS): description of surveillance methods. Am J Infect Control (1991) 3.00
Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes. Chest (1987) 2.97
Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med (1989) 2.97
CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Am J Infect Control (1992) 2.95
National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn Microbiol Infect Dis (1998) 2.94
The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med (1998) 2.94
Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med (1995) 2.86
Transmission of rhinovirus colds by self-inoculation. N Engl J Med (1973) 2.80
Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs. Proc Natl Acad Sci U S A (1999) 2.75
A cluster of Rhodococcus (Gordona) Bronchialis sternal-wound infections after coronary-artery bypass surgery. N Engl J Med (1991) 2.73
Characterization of the sequence of colonization and nosocomial candidemia using DNA fingerprinting and a DNA probe. J Clin Microbiol (1990) 2.72
Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis (1994) 2.67
Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model. Clin Infect Dis (1997) 2.67
National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis (1999) 2.63
Transfusion-associated acquired immunodeficiency syndrome. Evidence for persistent infection in blood donors. N Engl J Med (1985) 2.62
National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species. Diagn Microbiol Infect Dis (1998) 2.56
Development of Daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2005) 2.53
Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation. J Infect Dis (1996) 2.49
Identity and interspecific transfer of gentamicin-resistance plasmids in Staphylococcus aureus and Staphylococcus epidermidis. J Infect Dis (1980) 2.48
A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group. Crit Care Med (1995) 2.48
Are active microbiological surveillance and subsequent isolation needed to prevent the spread of methicillin-resistant Staphylococcus aureus? Clin Infect Dis (2005) 2.47
Vancomycin-resistant enterococci: why are they here, and where do they come from? Lancet Infect Dis (2001) 2.46
Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet (1996) 2.44
A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med (1996) 2.38
Medical and surgical treatment of parapneumonic effusions : an evidence-based guideline. Chest (2000) 2.36
Airborne spread of brucellosis. Ann N Y Acad Sci (1980) 2.33
The emergence of methicillin-resistant Staphylococcus aureus. Ann Intern Med (1982) 2.32
Laboratory proficiency test results on use of selective media for isolating Pseudomonas cepacia from simulated sputum specimens of patients with cystic fibrosis. J Clin Microbiol (1987) 2.31
Long-term survival and function after suspected gram-negative sepsis. JAMA (1995) 2.27
Pseudomonas cepacia typing systems: collaborative study to assess their potential in epidemiologic investigations. Rev Infect Dis (1989) 2.25
Nosocomial infections in pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Pediatrics (1999) 2.25
Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility. Clin Infect Dis (2000) 2.22
Investigation of the sequence of colonization and candidemia in nonneutropenic patients. J Clin Microbiol (1994) 2.22
Guideline for infection control in healthcare personnel, 1998. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol (1998) 2.20
Requirements for infrastructure and essential activities of infection control and epidemiology in hospitals: a consensus panel report. Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol (1998) 2.18
The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study. JAMA (1993) 2.18
Methicillin-resistant Staphylococcus aureus: microbiologic characteristics, antimicrobial susceptibilities, and assessment of virulence of an epidemic strain. J Infect Dis (1981) 2.12
Handwashing compliance by health care workers: The impact of introducing an accessible, alcohol-based hand antiseptic. Arch Intern Med (2000) 2.10
Importance of pre-existing co-morbidities for prognosis of septicemia in critically ill patients. Intensive Care Med (1993) 2.05
Septic shock: an analysis of outcomes for patients with onset on hospital wards versus intensive care units. Crit Care Med (1998) 2.04
Genetically diverse ceftazidime-resistant isolates from a single center: biochemical and genetic characterization of TEM-10 beta-lactamases encoded by different nucleotide sequences. Antimicrob Agents Chemother (1993) 2.03
Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program. Clin Infect Dis (1996) 2.03
Smallpox vaccination for investigators using vaccinia recombinants. Lancet (1989) 2.00
Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin Infect Dis (1996) 1.99
Hospital stay and mortality attributed to nosocomial enterococcal bacteremia: a controlled study. Am J Infect Control (1989) 1.98
Septicemia from intravenous infusions. N Engl J Med (1971) 1.96
Postoperative wound infection: a controlled study of the increased duration of hospital stay and direct cost of hospitalization. Ann Surg (1977) 1.95
Nosocomial enterococcal blood stream infections in the SCOPE Program: antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy. SCOPE Hospital Study Group. Diagn Microbiol Infect Dis (1997) 1.95
Antimicrobial resistance in intensive care units. Clin Chest Med (1999) 1.92
Epidemics of nosocomial urinary tract infection caused by multiply resistant gram-negative bacilli: epidemiology and control. J Infect Dis (1976) 1.92
Managing antibiotic resistance. N Engl J Med (2000) 1.90
Structural and phenotypic varieties of gentamicin resistance plasmids in hospital strains of Staphylococcus aureus and coagulase-negative staphylococci. Antimicrob Agents Chemother (1982) 1.89